Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2014

Nuclear medicine and the failed joint replacement:
Past, present, and future
C. J. Palestro
Zucker School of Medicine at Hofstra/Northwell

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Radiology Commons
Recommended Citation
Palestro CJ. Nuclear medicine and the failed joint replacement: Past, present, and future. . 2014 Jan 01; 6(7):Article 1998 [ p.].
Available from: https://academicworks.medicine.hofstra.edu/articles/1998. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works.

WJ R

World Journal of
Radiology
World J Radiol 2014 July 28; 6(7): 446-458
ISSN 1949-8470 (online)

Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.4329/wjr.v6.i7.446

© 2014 Baishideng Publishing Group Inc. All rights reserved.

REVIEW

Nuclear medicine and the failed joint replacement: Past,
present, and future
Christopher J Palestro
have been explored, but have their own limitations and
the results have been inconsistent. Fluorodeoxyglucose
(FDG)-positron emission tomography (FDG-PET) has
been extensively investigated for more than a decade
but its role in diagnosing the infected prosthesis has yet
to be established. Antimicrobial peptides bind to bacterial cell membranes and are infection specific. Data
suggest that these agents may be useful for diagnosing
prosthetic joint infection, but large scale studies have
yet to be undertaken. Although for many years nuclear
medicine has focused on diagnosing prosthetic joint
infection, the advent of hybrid imaging with singlephoton emission computed tomography (SPECT)/electronic computer X-ray tomography technique (CT) and
the availability of fluorine-18 fluoride PET suggests that
the diagnostic paradigm may be shifting again. By providing the anatomic information lacking in conventional
radionuclide studies, there is renewed interest in bone
scintigraphy, performed as a SPECT/CT procedure, for
detecting joint instability, mechanical loosening and
component malpositioning. Fluoride-PET may provide
new insights into periprosthetic bone metabolism. The
objective of this manuscript is to provide a comprehensive review of the evolution of nuclear medicine imaging of joint replacements.
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Abstract
Soon after the introduction of the modern prosthetic
joint, it was recognized that radionuclide imaging provides useful information about these devices. The bone
scan was used extensively to identify causes of prosthetic joint failure. It became apparent, however, that
although sensitive, regardless of how the images were
analyzed or how it was performed, the test was not
specific and could not distinguish among the causes of
prosthetic failure. Advances in anatomic imaging, notably cross sectional modalities, have facilitated the diagnosis of many, if not most, causes of prosthetic failure,
with the important exception of infection. This has led
to a shift in the diagnostic paradigm, in which nuclear
medicine investigations increasingly have focused on
diagnosing infection. The recognition that bone scintigraphy could not reliably diagnose infection led to the
development of combined studies, first bone/gallium
and subsequently leukocyte/bone and leukocyte/marrow imaging. Labeled leukocyte imaging, combined
with bone marrow imaging is the most accurate (about
90%) imaging test for diagnosing joint arthroplasty
infection. Its value not withstanding, there are significant disadvantages to this test. In-vivo techniques for
labeling leukocytes, using antigranulocyte antibodies

WJR|www.wjgnet.com

© 2014 Baishideng Publishing Group Inc. All rights reserved.

Key words: Bone scintigraphy; Positron emission tomog18
raphy; F-fluorodeoxyglucose; F-18; Fluoride-positron
emission tomography; Gallium; Infection; Labeled leukocytes; Prosthetic joint
Core tip: Advances in anatomic imaging, notably cross
sectional modalities, have facilitated the diagnosis of
many, if not most, causes of prosthetic failure, with the
important exception of infection. This has led to a shift
in the diagnostic paradigm, in which nuclear medicine
investigations increasingly have focused on diagnosing infection. This article is a comprehensive review of
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ganisms commonly encountered in infected joint replacements include Staphylococcus epidermidis and Staphylococcus
aureus. Streptococcus viridans, Escherichia coli, Enterococcus faecalis, and group-B Streptococcus are occasionally identified[4].
Early prosthetic joint infections occur by three months
after implantation, while delayed infections develop
within three months to one year after implantation. Late
infections are defined as infections that occur more than
one year after surgery. Early and delayed infections are
thought to be due to organisms introduced at surgery;
late infections are more likely to be due to hematogenous
spread[7].
The infected joint replacement is accompanied by an
inflammatory reaction characterized by a neutrophilic response, often intense[6]. Management of the infected joint
replacement consists of removal of the device, a lengthy
course (weeks to months) of antibiotic treatment, and
eventually a reimplantation procedure[8].
The correct therapeutic approach often depends on
the accurate differentiation of aseptic loosening and infection. This differentiation is not always obvious. Signs
and symptoms, except for pain, frequently are lacking.
Laboratory tests may be suggestive, but are not diagnostic, of infection. Joint aspiration with culture, the definitive preoperative test is specific, but sensitivity is variable[9,10]. Plain radiographs are not specific and prosthesis
related artifacts limit, to some degree, cross sectional
imaging studies.
Nuclear medicine procedures have, for many years,
contributed useful information about the painful joint
replacement. This manuscript is a comprehensive review
of the evolution of nuclear medicine imaging of joint
replacements.

the evolution of nuclear medicine imaging of joint replacements. In addition to conventional planar imaging
studies such as bone, gallium, and labeled leukocyte
imaging, single-photon emission computed tomography/electronic computer X-ray tomography technique
18
and positron emission tomography imaging with F18
fluorodeoxyglucose and F (NaI) are covered.
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INTRODUCTION
Contemporary joint arthroplasty procedures began less
than 75 years ago, when the predecessor of the modern
day hip replacement was introduced. A total hip arthroplasty includes both femoral and acetabular components; a hemiarthroplasty consists of only the femoral
component. These prostheses are anchored to bone by
various methods including polymethylmethacrylate and
osseous ingrowth into the device’s surface. Some devices
are coated with hydroxyapatite which induces new bone
formation and attaches to newly produced periprosthetic
osseous tissue. The acetabular component can be forced
into the acetabulum or secured by screws[1].
The predecessor of the contemporary knee prosthesis, developed about 40 years ago, consisted of a metallic
femoral component, together with plastic patellar and tibial components. Today’s devices provide improved range
of motion and greater durability of the components[1].
The vast majority of lower extremity joint replacement surgeries are successful; complications like infection, fracture, dislocation, and heterotopic ossification are
uncommon. At the present time the most common cause
of prosthetic failure is aseptic loosening, which develops
in more than a quarter of these devices and frequently
results from an inflammatory reaction instigated by prosthetic components[2,3]. The debris created by component
breakdown activates and draws surrounding leukocytes,
triggering secretion of cytokines and enzymes damaging
osseous tissues and leading to prosthetic loosening. The
cellular response is characterized by an influx of various types of leukocytes. Neutrophils, however, rarely are
present[4-6]. Most cases of aseptic loosening are treated
with one surgery, the single stage exchange arthroplasty.
Infection, which occurs in up to 2% of primary
implants, and up to 5% of revision implants is an uncommon complication of prosthetic joint surgery. Risk
factors for infection include operative suite characteristics, surgical complexity, condition of the osseous tissue
surrounding the prosthesis, and immune status of the
patient.
Bacteria bind to most joint replacement components
and once attached they secrete a protective biofilm[3]. Or-
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LITERATURE SEARCH
An electronic search with no language restrictions was
conducted in the bibliographic database PubMed using
the terms infection, osteomyelitis, arthroplasty, joint replacement, prosthetic joint, bone scintigraphy, bone marrow scintigraphy, gallium, labeled leukocytes, besilesomab,
sulesomab, sulfur colloid, antimicrobial peptides, positron
emission tomography, positron emission tomography
(PET), fluorodeoxyglucose (FDG), fluoride and 18F. The
list of articles generated was augmented by crosschecking
the reference lists of the retrieved papers. This was designed as a comprehensive review, not a meta analysis, of
the failed joint replacement and therefore neither specific
inclusion criteria nor any evidence based quality assessment tools were used to select the included articles.

RADIONUCLIDE IMAGING
Bone scintigraphy
The first, and undoubtedly the most extensively investigated, radionuclide procedure used for imaging joint
arthroplasties was bone scintigraphy. Technetium-99m
(99mTc) labeled diphosphonates, usually methylene di-
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A

Figure 1 Aseptically loosened right hip arthroplasty. A:
X-ray reveals medial protrusion of the acetabular component
of a painful 15 year old hip replacement. There is heterotopic
ossification around both greater trochanters (arrows); B:
On the 99mTc-methylene diphosphonate bone scan, there is
focally increased radiopharmaceutical accumulation at the
distal tip of the femoral component (arrow) of the right hip
replacement and lateral to the femoral neck (arrowhead)
corresponding to the heterotopic bone seen on the X-ray.
An aseptically loosened prosthesis was revised. Focally
increased radiopharmaceutical accumulation is present at
the tip of the femoral component of the asymptomatic left hip
arthroplasty (double arrows) which also was 15 years old.

B

A

B

C

D

Figure 2 Infected right hip arthroplasty. A: On the 99mTc-methylene diphosphonate bone scan, there is irregularly increased radiopharmaceutical accumulation
around the entire femoral component of the 2 years old cementless (revision) prosthesis, a pattern which some investigators have reported as specific for infection;
B-D: On the 99mTc-MDP bone scan, there is diffuse hyperperfusion, and hyperemia around the prosthesis on the flow and blood pool images, and diffusely increased
periprosthetic radiopharmaceutical on the delayed, bone image (same patient illustrated in Figure 2A); B: Flow; C: Blood pool; D: Bone.

tion critical to patient management[12].
In an effort to enhance its specificity, investigators
have studied periprosthetic uptake patterns on bone
scans. Williamson et al[13] suggested that focal periprosthetic uptake indicated loosening and diffuse uptake indicated infection (Figures 1, 2A). Williams et al[14] reported
that diffuse periprosthetic uptake was sensitive (100%),
but not specific (54%) for infection. Another group of
investigators came to the opposite conclusion: diffuse
periprosthetic uptake was specific, but not sensitive, for
infection[15]. Aliabadi et al[16] reported that bone scintigraphy did not differentiate septic from aseptic loosening
(Figure 3A).
Further confounding the analysis of periprosthetic
uptake is the numerous uptake patterns present around

phosphonate (MDP), are used for this study. Radiopharmaceutical incorporation into the bone depends on perfusion and rate of new bone formation. Imaging usually
is performed two to fours after injection. The procedure
also can be performed as a three phase bone scan: the
flow or perfusion phase, acquired immediately after radiopharmaceutical injection, followed immediately by the
soft tissue or blood pool phase. The third, or bone, phase
is performed between two and four hours later.
Gelman et al[10] reported that bone scintigraphy was
85% accurate for prosthetic hip loosening. Weiss et al[11]
reported that bone scintigraphy accurately identified
prostheses requiring surgical intervention. Another group
of investigators, however, observed that bone scintigraphy cannot determine the cause of the failure, informa-
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D

Figure 3 Aseptically loosened left hip replacement. A: On the 99mTc-MDP bone scan, there is diffusely increased radiopharmaceutical accumulation around the
femoral component of the cemented 2 years old prosthesis. Compare with Figure 2A; B-D: On the 99mTc-MDP bone scan, there is diffuse hyperperfusion, and hyperemia around the prosthesis on the flow and blood pool images, and diffusely increased periprosthetic radiopharmaceutical on the delayed, bone image (same patient
illustrated in Figure 3A), B: Flow; C: Blood pool; D: Delayed. The scan appearance is nearly identical to that of the infected prosthesis in Figure 2B.

tive study was not reliable for diagnosing either loosening
or infection. Complicating matters further is the paucity
of data on radionuclide bone imaging of hybrid and bipolar prostheses.
Assessment of knee replacements also is challenging. In one investigation periprosthetic activity was seen
around more than sixty percent of femoral components
and nearly 90% of tibial components of asymptomatic
devices for up to several years[22] (Figure 4). In an investigation of asymptomatic knee replacements with serial
bone scans periprosthetic activity generally diminished
over time after implantation. There was considerable
variation among patients. The authors stated, in order to
determine the significance of periprosthetic activity, serial scans need to be performed[23] (Figure 5A). Another
group of investigators reported that bone scintigraphy
does not accurately diagnose the infected knee arthroplasty[24].
Performing radionuclide bone imaging as a threephase study has been advocated to enhance its specificity[25]. Nagoya et al[26] reported that the test was 88% sensitive and 90% specific for hip replacement infection. Most
other investigations, however, have reported low sensitivity, low specificity, or both[24,27-30] (Figures 2B and 3B).
Regardless of how bone scintigraphy is performed, its
accuracy for diagnosing complications of lower extremity
joint prostheses is about 50%-70%. At the present time
this test is used primarily for screening purposes. A nor-

Figure 4 Asymptomatic right knee arthroplasty. On the 99mTc-MDP bone
scan, there is irregular, intense radiopharmaceutical accumulation around the
long stemmed tibial component of a three year old right knee replacement. The
femoral component is unremarkable. The patient had a history of breast carcinoma and bone scintigraphy was performed as part of a routine evaluation for
metastatic disease.

asymptomatic devices. For up to 12 m after insertion of
a hip prosthesis, periprosthetic uptake is very variable;
after this time ten percent of asymptomatic cemented
hip prostheses still demonstrate uptake[17]. Increased periprosthetic uptake is even more frequent in cementless
devices[18-20].
Gallo et al[21] studied 27 hydroxyapatite coated hip replacements, observing that while a normal study excluded
aseptic loosening with a high degree of certainty, a posi-
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Figure 5 Aseptically loosened right knee
arthroplasty. A: On the 99mTc-methylene diphosphonate (MDP) bone scan, performed
about 6 mo after implantation (left), shows
mildly increased radiopharmaceutical accumulation around the femoral and tibial components. On the repeat study, performed 9
mo later (15 mo after implantation), there
is intensely increased radiopharmaceutical accumulation around the tibial component, while activity around the femoral
component has resolved. An aseptically
loosened tibial component was revised; B:
On the 99mTc-MDP bone scan (left) there is
increased radiopharmaceutical accumulation around the tibial component of both the
symptomatic right and asymptomatic left
knee prostheses. There is normal periprosthetic distribution around both prostheses
on the gallium-67 image (right), and the
combined study is negative for infection; C:
On the 99mTc-MDP bone scan (left) there is
increased radiopharmaceutical accumulation around the tibial component of the
symptomatic right and faintly increased
accumulation around the tibial component
of the asymptomatic left knee prosthesis.
On the gallium-67 image (right), in contrast
to the bone scan, there is increased radiopharmaceutical accumulation around the
femoral component (arrows) of the right
knee replacement, while activity around the
tibial component is normal. There is normal
periprosthetic gallium activity around the asymptomatic left prosthesis. The distribution
of activity around the right knee prosthesis
on the bone and gallium studies is spatially
incongruent and the combined study is
(false) positive for infection. Aseptic loosening of joint replacements often is accompanied by an intense inflammatory response
and gallium cannot reliably differentiate
infection from inflammation.

A

B

C

Figure 6 Normal 99mTc-methylene diphosphonate
bone scans of bilateral hip (left) and right knee (right)
prostheses. A normal bone scan is defined as a scan in
which periprosthetic activity is indistinguishable from adjacent, non-articular bone. The bone scan has a high negative predictive value and therefore a normal study makes
it very unlikely that the patient’s symptoms are related to
the prosthesis.

mal study makes it very unlikely that the patient’s symptoms are related to the prosthesis (Figure 6).

(gallium) imaging. Gallium uptake in infection likely is
due to several factors including increased blood flow and
vascular membrane permeability at inflammatory sites,
lactoferrin binding and siderophore and bacterial uptake
of gallium. Some gallium may be transported by leukocytes. Imaging typically is performed two to three days
after injection[31].

Gallium scintigraphy
Over the years various techniques designed to overcome
the limitations inherent in bone scintigraphy have been
investigated. One of the earliest was gallium-67 citrate
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Reing et al[32] observed that bone scintigraphy was
sensitive (100%), but not speciﬁc (15%), while gallium
was sensitive (95%) and specific (100%). Other investigators have reported similar results[15,33,34]. Aliabadi et al[16], in
contrast, found, for the infected hip replacement, gallium
scintigraphy was specific (100%) but insensitive (37%).
While some investigators have evaluated gallium imaging alone, other investigators have interpreted bone
and gallium imaging together. Standardized criteria for interpretation of the combined study have been developed.
The test is positive for osteomyelitis when distribution
of the two tracers is different or, when their distribution
is the same and the relative intensity of gallium uptake
exceeds that of the bone agent. The test is equivocal for
osteomyelitis when the distribution of the two radiotracers is the same, both spatially and in intensity. The test is
negative for osteomyelitis when the gallium images are
normal, regardless of the bone scan findings, or, when
the distribution of the two tracers is the same and the
relative intensity of gallium uptake is less than that of the
bone agent (Figure 5B and 5C)[1].
Tehranzadeh et al[35] reported that bone/gallium imaging was 95% accurate for prosthetic joint infection. In
most other series the test has been less successful. In 30
patients the test identified only 50% of the infected joint
replacements[14]. Gómez-Luzuriaga et al[36] found that
bone/gallium imaging was 80% accurate for prosthetic
joint infection. Kraemer et al[37] reported that the combined test was 38% sensitive, and 100% specific for hip
replacement infection. Merkel at al[38,39] evaluated bone/
gallium imaging in an animal investigation and in patients
and reported similar results.
Over the years the use of gallium for joint replacement infection has declined, and it has been replaced in
most circumstances by labeled leukocyte imaging.

observed that WBC activity around infected prostheses
was always significant. Rand et al[43] found that sensitivity
and specificity for prosthetic knee infection was 83% and
85% when moderately to markedly increased periprosthetic activity was present. Magnuson et al[27], in an investigation of 98 patients reported sensitivity and specificity
for WBC imaging of 88% and 73% respectively, for
lower extremity joint replacement infection.
In some studies, WBC imaging was specific, but not
sensitive for prosthetic joint infection, while in others the
test was sensitive but not specific[15,34,44,45].
Poor sensitivity has been ascribed to the chronicity
of the process; i.e., presumably the neutrophilic response
had ceased, or at least waned, by the time the patient underwent imaging. Neutrophils, however, almost always are
present in the infected joint replacement, regardless of
the duration of symptoms, so chronicity does not explain
low sensitivity.
Poor specificity often has been attributed to nonspecific inflammation. It was thought that false positive
results were secondary to labeled leukocyte accumulation
in aseptic inflammation. Although aseptic inflammation
around a prosthetic joint replacement is often accompanied by an intense leukocyte response, neutrophils rarely
are present. In most situations, primarily neutrophils are
labeled and the sensitivity of WBC imaging is greatest
for detecting infections characterized by a neutrophilic
response. The test is not at all sensitive, however, for detecting inflammation that is not neutrophil mediated[40].
Given the lack of a neutrophilic response in the aseptically inflamed prosthesis, inflammation cannot be the
sole explanation for poor specificity.
What is the reason for the variable and often contradictory observations? WBC images usually are interpreted
by comparing intensity of periprosthetic uptake to intensity of uptake in some predefined reference point, typically an area of presumably normal bone marrow. Studies
in which intensity of labeled leukocyte activity in the area
of interest exceeds intensity of activity in the reference
point are classified as positive for infection; otherwise the
study is negative. The likelihood of infection, however, is
not related to intensity of periprosthetic activity (Figures
7A and 8A). In one investigation[46] the accuracy of the
test varied with the manner in which the studies were
interpreted. The mere presence of periprosthetic activity, regardless of intensity, was 100% sensitive and 23%
specific. Using periprosthetic activity exceeding activity in
the contralateral extremity as the criterion for infection,
sensitivity was 65%, specificity was 61%[46].
There is another problem inherent in the interpretation of WBC images. Leukocytes, labeled or
otherwise, accumulate in bone marrow, the normal
distribution of which can be variable. Generalized, as
well as localized, marrow expansion alter the “normal”
distribution of marrow making it difficult to differentiate
labeled leukocyte uptake in unusually located, but normal,
marrow from uptake in infection[47].
In a manner analogous to bone/gallium imaging, it

Labeled leukocyte scintigraphy
The accumulation of in-vitro labeled white cells at a site
of infection depends on chemotaxis, the quantity and
sorts of leukocytes labeled, and the primary cellular response in a particular situation. Neutrophils usually comprise the majority of leukocytes labeled and consequently
sensitivity of WBC imaging is highest for neutrophilmediated inflammatory processes[40]. When indium-111 is
the radiolabel, images are acquired 18-30 h after administration. When technetium-99m is the radiolabel, imaging
usually is performed four to six and repeated 18 to 30 h
after administration.
One would anticipate that, because neutrophils invariably are present labeled leukocyte (WBC) imaging would
accurately diagnose prosthetic joint infection. Interestingly, for quite some time, the value of the test was a subject
of controversy.
In a canine study, Merkel et al[38] reported that WBC
imaging was 94% sensitive and 86% specific for prosthetic infection. Pring at al[41] found that WBC imaging
was 100% sensitive and 89.5% specific for the infected
prosthetic joint. In another investigation, Pring et al[42]
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Figure 7 Infected left hip arthroplasty. A: On this anterior image from an indium-111 labeled leukocyte study, periprosthetic activity (arrows) is similar in intensity
to activity in the contralateral lower extremity and less intense than pelvic activity, areas typically used as reference points when interpreting these studies. Because
studies in which the intensity of labeled leukocyte activity in the region of interest does not exceed intensity of activity in the reference point, this study could be erroneously interpreted as negative for infection; B: The distribution of periprosthetic activity on the labeled leukocyte (left, 111In-WBC) and sulfur colloid bone marrow
(right, 99mTc-SC) images is spatially incongruent (arrows), i.e., there is activity in the left hip joint on the labeled leukocyte image, but not on the bone marrow image.
The combined study is positive for infection. (Same patient illustrated in Figure 7A); Although the planar combined indium labeled leukocyte/bone marrow study (C,
left, 111In-WBC; right, 99mTc-SC) is positive for infection (arrows), precise information about the location and extent of infection is lacking. On the fused images (bottom
row) from the labeled leukocyte SPECT/CT (D) the location of the abnormal labeled leukocyte accumulation (arrows) can clearly be seen adjacent and extending to
the prosthesis at the level of the greater trochanter. Note also the adjacent hypodense area in the soft tissues, consistent with abscess. Bone marrow SPECT/CT images (E) acquired simultaneously with the labeled leukocyte images in 16a confirm that the activity on the labeled leukocyte component of the examination is due to
infection. Whether or not the bone marrow component of the SPECT/CT study contributes additional information beyond what planar imaging provides remains to be
determined.

fection, but improved to 85% with the addition of bone
imaging[44]. Johnson et al[45] observed that the combined
test was more speciﬁc and only slightly less sensitive than

has been suggested that interpreting WBC images together with bone scans improves results. In one study, WBC
imaging alone was 45% speciﬁc for prosthetic joint in-
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A

B

Figure 8 Aseptically loosened left knee arthroplasty. A: On this anterior image from an indium-111 labeled leukocyte study, there is intense periprosthetic activity
around both the tibial and femoral components (arrows), while there is no activity around the contralateral knee. The study could be interpreted erroneously as positive for infection. Compare the intensity of activity around this prosthesis with the intensity of activity around the infected hip arthroplasty in Figure 7A. As these two
cases illustrate, the intensity of labeled leukocyte activity around a prosthetic joint is not a reliable criterion for determining the presence or absence of infection; B:
The distribution of periprosthetic activity on the labeled leukocyte (left, 111In-WBC) and sulfur colloid bone marrow (right, 99mTc-SC) images is virtually identical (spatially
congruent) and the combined study is negative for infection. The periprosthetic activity on the labeled leukocyte image is due to marrow, not to infection. Performing
complementary bone marrow imaging eliminates the two major difficulties inherent in the interpretation of labeled leukocyte images: variable intensity of periprosthetic
activity and differentiating bone marrow activity from infection. Same patient illustrated in Figure 8A.

WBC imaging for hip replacement infection.
Palestro et al[24] observed that the addition of bone
imaging did not increase the accuracy of WBC imaging
for knee arthroplasty infection. In another investigation,
the accuracy of the combined test for lower extremity
joint replacement infection was only 76%[48]. In an investigation of patients with asymptomatic cementless hip
replacements, using standard interpretive criteria, WBC/
bone imaging would have been classified as positive for
infection 15% of the time[18].
Another approach to WBC imaging of the prosthetic
joint is to combine the test with bone marrow imaging,
which usually is performed with 99mTc sulfur colloid. Both
radiopharmaceuticals accumulate in the reticuloendothelial cells of the bone marrow. The distribution of marrow
activity on WBC and bone marrow images parallel one
another in most situations. The one exception is osteomyelitis, in which the distribution of these two agents
differs, i.e., the images are spatially incongruent (Figures
7B and 8B)[47].
Mulamba et al[49] reported 92% sensitivity and 100%
specificity for prosthetic hip infection. Palestro et al[24,46]
reported similar results for infected hip and knee arthroplasties. Love et al[50] studied 59 lower extremity joint
prostheses and reported that WBC/marrow imaging was
95% accurate for infection. El Espera et al[51] reported
91% accuracy for lower extremity prosthetic joint infection.
Virtually all of the investigations published to date
indicate that WBC/marrow imaging is specific for joint
replacement infection. In most of the investigations the
test has proved to be sensitive as well. Joseph et al[52] however, reported that although test was 100% specific, the
test was only 66% sensitive. Pill et al[53] reported similar
results. It is unfortunate indeed that no illustrations of
false negative studies, the salient point of these investigations, were provided in either publication.

WJR|www.wjgnet.com

There are some data that indicate performing WBC
imaging at more than one time point could obviate the
need for marrow imaging. The hypothesis is that images
acquired shortly after injection represent marrow while
images acquired later represent infection. Difference in
uptake patterns over time is indicative of infection. The
accuracy of the test improved from about 75% when images were interpreted visually, to about 95% when semiquantitative analysis was performed[54].
There are, unfortunately, disadvantages to WBC/
marrow imaging. The leukocyte labeling procedure is
demanding, not routinely available, and involves contact
with blood products. Labeling enough leukocytes to produce diagnostically useful studies can be difficult in immunocompromised individuals. Image quality, especially
when using indium-111, is not ideal. The need to perform
marrow imaging is another disadvantage. Radiolabeled
antigranulocyte antibodies and antibody fragments have
been explored as alternatives.
Besilesomab is a murine monoclonal G1 immunoglobulin that binds to Normal Cross-reactive Antigen-95
on leukocytes[55]. Using visual image analysis the sensitivity and specificity for joint replacement infection range
from 67%-91% and 57%-75%, respectively. By performing complementary bone imaging or semiquantitative
analysis, sensitivity ranged from 67% to 100%; specificity
ranged from 84% to 100%[56-59].
Sulesomab is a fragment antigen binding (Fab’) portion of a murine monoclonal G1 immunoglobulin that
binds to Nonspecific Cross-reactive Antigen-90 on leukocytes[55]. Reported sensitivity and specificity for prosthetic
joint infection have ranged from 75% to 93% and 65% to
86%, respectively[60-62]. Dual time point imaging and time
activity curve analysis may improve test accuracy[63-65].
Somewhat surprisingly, even though in-vivo labeled
leukocytes accumulate in the marrow, in much the same
way that in-vitro labeled leukocytes do, scant attention has
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was 95% sensitive and 93% specific for diagnosing infection. Fifty one of the prostheses, including ten infected
devices, also were studied with WBC/marrow imaging.
The sensitivity and specificity of WBC/marrow imaging
in this subgroup were 50% and 95.1%, respectively.
Manthey et al[72] reported that FDG was 96% accurate
for prosthetic joint infection. They also reported that activity around the femoral head and neck indicated synovitis plus infection, observations that contradict those of
previous investigations[68,69].
Stumpe et al[30] observed that, in patients with painful
hip replacements, intense bone prosthesis interface activity was reasonably specific (81% for reader 1 and 85% for
reader 2), but not sensitive (33% for reader 1, 56% for
reader 2) for diagnosing infection (33% for reader 1, 56%
for reader 2). The accuracy of the test, for both readers, was 69%. Bone scintigraphy was more accurate than
FDG-PET (80% vs 69%) in this investigation.
Van Acker et al[73] studied 21 patients with suspected
prosthetic knee infection. FDG-PET was 100% sensitive
and 73% specific. Sensitivity and specificity of WBC/
bone imaging was 100% and 93%, respectively. Vanquickenborne et al[74] reported similar results.
García-Barrecheguren et al[75] studied 24 hip replacements. FDG-PET was neither sensitive (64%) nor specific (67%) for infection. Delank et al[76] studied 27 patients
with failed hip and knee replacements and concluded
that FDG-PET could not reliably differentiate between
infection and aseptic inflammation.
Love et al[50] evaluated 59 failed lower extremity joint
prostheses with FDG-PET and WBC/marrow imaging.
Among the criteria used for image interpretation, bone
prosthesis interface activity, with a target to background
ratio greater than 3.6 for hip replacements and 3.1 for
knee replacements was the most accurate (71%) for diagnosing infection. The accuracy of WBC/marrow imaging, in contrast, was 95%.
In a met analysis sensitivity and specificity of FDGPET for prosthetic joint infection were 82% and 87% respectively[77]. In view of the large number of inconsistent
and contradictory results that have been reported to date,
the place of FDG-PET in the assessment of the prosthetic joint remains to be determined.

been paid to combining these studies with bone marrow
imaging. In one of the few investigations in which complementary bone marrow imaging was performed, Sousa
et al[66] reported that the specificity of 99mTc-sulesomab
increased from 20% to 100%, when complementary marrow imaging was performed.
Using in-vivo labeled leukocytes overcomes the limitations of the in-vitro labeling procedure. Based on published data however, an additional study, either bone or
marrow imaging probably still needs to be performed.
Furthermore, besilesomab, which is a murine antibody,
incites a human antimurine antibody (HAMA) response
in up to 30% of patients[57]. Patients should be screened
for HAMA and a positive result is a contraindication to
the procedure. Because of immunogenicity concerns, patients should not undergo repeat studies with this agent.
Not surprisingly, in-vivo labeled WBC imaging, using antigranulocyte antibodies, has not gained wide acceptance in
the diagnostic workup of the painful joint replacement.
18

F-fluorodeoxyglucose
F-fluorodeoxyglucose (FDG) is transported into cells
via glucose transporters and phosphorylated to 18F-2’FDG-6 phosphate but is not metabolized. FDG uptake
depends on cellular metabolic rate and the number of
glucose transporters. Activated leukocytes demonstrate
increased expression of these transporters with increased
affinity for FDG in the presence of cytokines and growth
factors. There are several advantages to FDG. The procedure is completed within two hours after injection. Target
to background ratio is high. Images obtained with positron emission tomography (PET) have much higher resolution than those obtained with conventional agents[67].
Several investigators have studied the role of FDGPET for evaluating painful lower extremity joint prostheses. Zhuang et al[68] evaluated 74 lower extremity joint
prostheses and reported that increased activity along
the bone prosthesis interface was 89.5% and 77.8 % for
diagnosing infection of hip and knee arthroplasties, respectively. Accuracy depended on location, not intensity,
of FDG uptake. Using similar criteria Chacko et al[69] reported that the test was 92% sensitive and 97% specific
for hip replacement infection. Infection could not be differentiated from aseptic loosening based on intensity of
periprosthetic uptake.
Reinartz et al[29] studied 92 hip prostheses with three
phase bone scintigraphy and FDG-PET. Sensitivity,
specificity and accuracy of three phase bone scintigraphy
were 68%, 76% and 74% vs 94%, 95%, and 95%, respectively, for FDG-PET. Activity around the acetabular component and proximal aspect of the femoral component
on FDG-PET images was not associated with infection.
Pattern, but not intensity, of periprosthetic uptake was
useful for differentiating infection from aseptic loosening.
Cremerius et al[70] reported that FDG was 89% accurate
for hip replacement infection. Gravius et al[71] reported
similar results. Pill et al[53] studied 92 painful hip prostheses, including 21 infected devices, and reported that FDG
18
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Infection-specific tracers
Given the dramatic differences in the management of
aseptic loosening and infection of prostheses, the importance of accurately differentiating between these two
conditions cannot be overstated. The development of an
infection specific imaging agent would be a welcome improvement over the current procedures.
The potential of radiolabeled antibiotics as “infectionspecific” radiopharmaceuticals has been explored. The
hypothesis is that the radiolabeled antibiotic enters, and is
metabolized by, bacteria and could be used to accurately
localize infection. Although the results of initial studies were encouraging, subsequent investigations raised
significant doubts about the validity of this concept and
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enthusiasm for radiolabeled antibiotics has faded[78-81].
Antimicrobial peptides bind to the bacterial cell membrane. Their expression may be constant or induced on
contact with microbes. They also can be transported via
leukocytes[82]. 99mTc-UBI 29-41, a radiolabeled synthetic
fragment of the naturally occurring human antimicrobial
peptide ubiquicidin, appears to be able to differentiate
between infection and sterile inflammation[83]. Recent
data suggest that this agent is both sensitive and specific
for prosthetic joint infection[84,85].

tests at different times and possibly different locations,
and a diagnosis could be made more expeditiously.
Flourine18-fluoride-PET (fluoride-PET) bone imaging shows great promise in the evaluation of joint
arthroplasties. Some investigators have used this test in
a manner analogous to that of conventional bone scintigraphy. Sterner et al[90] compared the results of fluoridePET bone scans to plain radiographs in 14 patients with
painful knee arthroplasties. Sensitivity, specificity, and
accuracy of the fluoride PET study for detecting aseptic
loosening were 100%, 56%, and 71%, respectively. Sensitivity, specificity, and accuracy of plain radiographs were
43%, 86%, and 64%, respectively.
Other investigators have explored the potential of fluoride-PET for studying bone metabolism. An important
concern in patients undergoing hip resurfacing arthroplasty is the viability of the remaining femoral head, and
the risk of postoperative fracture or avascular necrosis.
Conventional radiographs are of limited utility, because
the femoral head is obscured by the overlying metallic
components of the device. Ullmark et al[91] reported that
fluoride PET correctly identified aseptic necrosis in three
of fourteen patients with a hip resurfacing arthroplasty.
Radiographs were negative in all cases. These investigators concluded that fluoride-PET is useful for evaluating
bone metabolism at resurfacing arthroplasty. In another
investigation, Ullmark et al[92] studied bone mineralization
around the femoral component of cementless hip arthroplasties. They concluded that fluoride-PET is a valuable
tool for analysis of bone mineralization patterns around
uncemented femoral stems and together with the modified Polar Map system could be useful to study metabolic
bone responses to prosthetic implants.
There are recent data that suggest that Fluoride-PET
is a valuable tool to analyse bone formation and secondary stabilization of a press-fit acetabular cup in patients
undergoing total hip arthroplasty[93].

FUTURE
Initial data suggest that single-photon emission computed
tomography (SPECT)/electronic computer X-ray tomography technique (CT) may contribute useful information
to the evaluation of the failed joint arthroplasty. For
example, nuclear arthrography often is performed as a
dual isotope procedure, in which the bone scan provides
“anatomic detail” and another radiopharmaceutical, often
an indium-111 labeled complex, is used for the arthrographic component. A potential alternative to the dual
isotope technique is SPECT/CT arthrography, in which
the CT component provides the anatomic landmarks
necessary for radiopharmaceutical localization. In one investigation SPECT/CT was significantly better than planar imaging for the acetabular cup of hip prostheses[86].
For knee arthroplasties, SPECT/CT offered a significant
improvement over planar imaging for detecting femoral
component loosening. SPECT/CT also was better than
planar imaging for detecting tibial component loosening
but statistical significance was not reached.
Hirschmann et al[87] reported that SPECT/CT could
detect mechanical loosening, joint instability, component
malposition, and patellofemoral problems in patients with
knee arthroplasties. In another investigation of knee arthroplasties, SPECT/CT significantly altered the working
diagnosis and proposed treatment, and changed the initial
intention to revise or treat the patients non-surgically.
The diagnosis made with SPECT/CT was correct in all
patients who underwent surgery[88].
Graute et al[89] evaluated the contribution of SPECT/
CT as an adjunct to planar scintigraphy with 99mTc-besilesomab for diagnosing and localizing low-grade prosthetic
joint infection. Planar imaging was 66% sensitive, and
60% specific for infection. Combining planar imaging
with SPECT/CT, sensitivity and specificity improved to
89% and 73%, respectively.
The potential impact of SPECT/CT extends well
beyond diagnosing infection. In patients with a positive
study, for example, the examination could provide information about the extent of infection as well as other abnormalities involving the native bone and the prosthesis
(Figure 7C-E); joint aspiration and culture could be performed at the same time. In patients with negative studies
the CT component could provide information about other causes of prosthetic failure. In such a scenario patients
would be spared the need to undergo multiple imaging

WJR|www.wjgnet.com

CONCLUSION
At the moment, nuclear medicine is most valuable for
determining whether or not a painful joint prosthesis is
infected. WBC/marrow imaging, currently, is the best
available imaging test for this purpose. Preliminary data
suggest that SPECT/CT, in addition to providing information about the presence and extent of infection, may
be able to provide additional information about other
conditions that cause joint replacements to fail. FluoridePET also may provide hitherto unknown insight into
periprosthetic bone metabolism.
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